TSLP VACCINE FOR THE TREATMENT OF TH2 MEDIATED INFLAMMATORY CONDITIONS

摘要

The invention relates to compositions for the treatment of TH2 mediated i nflammatory conditions. The compositions are vaccines comprising a non-prima te TSLP or fragments thereof to be used as a vaccine to treat humans with ex cessive TH2 mediated inflammatory conditions. For the treatment of TH2 media te inflammatory conditions in other non-human mammals the TSLP of the specie s to be vaccinated is being used as antigen.